Here we demonstrate that elevated expression of thioredoxin domain-containing protein 12 (TXNDC12) in HNSCC is associated with adverse clinical outcomes and reduced survival. This evidence concerns the gene TXNDC12 and head and neck squamous cell carcinoma.